Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.
Authors:
- J E MullerJMJ E Muller
- J MorrisonJMJ Morrison
- P H StonePSP H Stone
- R E RudeRRR E Rude
- B RosnerBRB Rosner
- R RobertsRRR Roberts
- D L PearleDPD L Pearle
- Z G TuriZTZ G Turi
- J F SchneiderJSJ F Schneider
- D H SerfasDSD H Serfas
- 1 April 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 69 (4) , 740-747
Abstract
Preliminary clinical and laboratory observations suggest that nifedipine might prevent progression of threatened myocardial infarction by reversing coronary spasm or might limit necrosis during the course of acute myocardial infarction. We screened 3143 patients with ischemic pain of greater than 45 min duration and randomly assigned 105 eligible patients with threatened myocardial infarction and 66 with acute myocardial infarction to receive nifedipine (20 mg orally every 4 hr for 14 days) or placebo plus standard care. Treatment was started 4.6 +/- 0.1 hr after the onset of pain. Infarct size index was calculated by the MB-creatine kinase (CK) method and expressed as CK-geq/m2 +/- SE. The incidence of progression to infarction among patients with threatened myocardial infarction was not significantly altered by nifedipine (36 of 48 [75%] for placebo-treated and 43 of 57 [75%] for nifedipine-treated patients). Furthermore, infarct size index was similar among placebo- and nifedipine-treated patients (16.9 +/- 1.5 MB-CK-geq/m2, n = 65, and 17.0 +/- 1.5 MB-CK-geq/m2, n = 68, respectively) with threatened myocardial infarction who exhibited infarction and for those with acute myocardial infarction. Among the 171 eligible patients randomly assigned to drug or placebo, 6 month mortality did not differ significantly (8.5% for placebo vs 10.1% for nifedipine, NS), but mortality in the 2 weeks after randomization was significantly higher for nifedipine-treated patients (0% for placebo compared with 7.9% for nifedipine, p = .018).(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 26 references indexed in Scilit:
- Coronary Spasm Producing Coronary Thrombosis and Myocardial InfarctionNew England Journal of Medicine, 1983
- A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intracoronary Fibrinolytic Therapy in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Protective effects on isolated hearts with developing infarction: Slow channel blockade by diltiazem versus beta-adrenoceptor antagonism by metoprololThe American Journal of Cardiology, 1982
- Failure of nifedipine therapy to reduce myocardial infarct size in the baboonThe American Journal of Cardiology, 1982
- Effect of diltiazem in patients with variant angina: A randomized double-blind trialAmerican Heart Journal, 1981
- Nifedipine Therapy for Coronary-Artery SpasmNew England Journal of Medicine, 1980
- Nifedipine therapy for stable angina pectoris: Preliminary results of effects on angina frequency and treadmill exercise responseThe American Journal of Cardiology, 1979
- Coronary Vasospasm as a Possible Cause of Myocardial InfarctionNew England Journal of Medicine, 1978
- Maximal revascularization (reperfusion) in intact conscious dogs after 2 to 5 hours of coronary occlusionThe American Journal of Cardiology, 1975